ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Dietary Sodium Intake And Blood Pressure In Living Kidney Donors (SPLID): Rationale And Design Of A Pilot Single-center Crossover Single-blind Randomized Controlled Trial

E. Tantisattamo1, U. G. Reddy1, A. J. Ferrey1, H. Ichii2, D. C. Dafoe2, H. Moradi1, C. M. Rhee1, K. Kalantar-Zadeh1

1Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine, Orange, CA, 2Division of Kidney and Pancreas Transplantation, Department of Surgery, University of California Irvine School of Medicine, Orange, CA

Meeting: 2022 American Transplant Congress

Abstract number: 9046

Keywords: Hypertension, Kidney, Living donor, Proteinuria

Topic: Basic & Clinical Science » Basic & Clinical Science » 74 - Clinical Trials

Session Information

Session Name: Clinical Trials

Session Type: Poster Abstract

Date: Saturday, June 4, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:30pm-7:00pm

Location: Hynes Halls C & D

*Purpose: Since living kidney donors(LKD) are generally healthy and non-hypertensive individuals, non-pharmacologic interventions are likely to be an acceptable and practical approach to preventing hypertension(HTN). This trial aims to assess the feasibility of the design and impact of low dietary sodium intake(DSI) on blood pressure(BP), kidney function, and albuminuria in LKD.

*Methods: Dietary Sodium Intake and Blood Pressure in Living Kidney Donors (SPLID) is a pilot single-center crossover single-blind randomized controlled trial that aims to evaluate the feasibility of the study design and test the effect of low compared to standard DSI on the change in BP, glomerular filtration rate (GFR), and microalbuminuria in LKD during a 4-month study period. LKD 5 to 12 months post-donation who are not on antihypertensives are invited to participate in this study. After a 1-month run-in period when the participants take medium sodium diet (Na 3-3.5 g/day), they will be randomly assigned to low (2-2.3 g/day) or standard sodium (4-6 g/day) diet for 1 month (pre-crossover). After that, they will undergo a 1-month braking period with medium sodium intake, and then are crossed over to take standard or low sodium diet for 1 month (post-crossover) (Figure 1). Changes in BP, GFR, and microalbuminuria during the 1-month pre- and post-crossover periods are examined using generalized estimating equation.

*Results: Rationale: Compensatory glomerular hyperfiltration post-donation can lead to pathologic renal structural and functional alterations and subsequently neurohormonal changes that contribute to sodium and water retention, ultimately leading to HTN and proteinuria. Low DSI can modulate renal blood flow and reduce glomerular hyperfiltration. This may mitigate the renal pathophysiological changes associated with kidney donation and reduce the risk of HTN, kidney function decline, and proteinuria in LKD.

*Conclusions: The findings of this study will provide the scientific and operational feasibility data needed to design and conduct larger trials in subjects post-donation. This study also provides early proof of concept evidence that dietary sodium intervention can impact BP, kidney function and albuminuria in LKD (NCT05041829).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Tantisattamo E, Reddy UG, Ferrey AJ, Ichii H, Dafoe DC, Moradi H, Rhee CM, Kalantar-Zadeh K. Dietary Sodium Intake And Blood Pressure In Living Kidney Donors (SPLID): Rationale And Design Of A Pilot Single-center Crossover Single-blind Randomized Controlled Trial [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/dietary-sodium-intake-and-blood-pressure-in-living-kidney-donors-splid-rationale-and-design-of-a-pilot-single-center-crossover-single-blind-randomized-controlled-trial/. Accessed May 9, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences